| Description: |
INV-202 is an orally active type 1 cannabinoid receptor (CB1) blocker that blocks the receptor protein CB1 in peripheral tissues such as adipose tissue, gastrointestinal tract, kidneys, liver, pancreas, muscle, and lungs, and can be used in studies related to obesity. |
| Stability and Solubility Advice: |
Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |
